Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification

MLA

Ungan, Gulnur, et al. “Metastatic Melanoma Treated by Immunotherapy: Discovering Prognostic Markers from Radiomics Analysis of Pretreatment CT with Feature Selection and Classification.” International Journal of Computer Assisted Radiology and Surgery, vol. 17, no. 10, Oct. 2022, pp. 1867–77. EBSCOhost, https://doi.org/10.1007/s11548-022-02662-8.

APA

Ungan, G., Lavandier, A.-F., Rouanet, J., Hordonneau, C., Chauveau, B., Pereira, B., Boyer, L., Garcier, J.-M., Mansard, S., Bartoli, A., & Magnin, B. (2022). Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification. International Journal of Computer Assisted Radiology and Surgery, 17(10), 1867–1877. https://doi.org/10.1007/s11548-022-02662-8

Chicago

Ungan, Gulnur, Anne-Flore Lavandier, Jacques Rouanet, Constance Hordonneau, Benoit Chauveau, Bruno Pereira, Louis Boyer, et al. 2022. “Metastatic Melanoma Treated by Immunotherapy: Discovering Prognostic Markers from Radiomics Analysis of Pretreatment CT with Feature Selection and Classification.” International Journal of Computer Assisted Radiology and Surgery 17 (10): 1867–77. doi:10.1007/s11548-022-02662-8.